Multidisciplinary Lung Cancer Conference 2019
1 – 2 March 2019
Mandarin Orchard Hotel, Singapore

Programme At A Glance

The 4th Multidisciplinary Lung Cancer Conference


Date: 1st – 2nd March 2019


Venue: Mandarin Orchard Singapore


Day 1 (1 March 2019) Day 2 (2 March 2019)
Opening and Keynote Session Welcome Coffee / Tea and Poster Viewing / Breakfast Tumor Board / Interactional / Oral Presentation
Welcome Address
(Chair of LCCS)
Introduction to 4th Multidisciplinary Lung Cancer Conference
(Chair of MLCC 2019)
Keynote address: Translational Research
Session 1: Lung Cancer Screening Session 5: Updates in Other Thoracic Cancers
Lung Cancer Screening Mesothelioma – Updates
Management of Indeterminate Pulmonary Nodule Thymic Tumours – Updates
Current Directions for Screening in Singapore (LCG Program) Small Cell Lung Cancers / Large Cell NEC – What’s New
Imaging: Role of AI for Early Detection Panel Discussion
Tea Symposium Tea Symposium
Session 2: Pathology Session 6: Advanced Stage I
Molecular Testing for NSCLC 2019 Role of Surgery in Stage IV Disease with Oligometastasis
Incorporating Emerging Technologies Into The Clinic (Liquid Biopsies, NGS) Radiation: Role of Radical RT for Oligomet Disease and Squencing
Value Driven Health Care in Cancer Role of Ablation
Panel Discussion / Voting
Next Generation Sequencing: Ready for Prime Time?
Medonco: Oligometastatic Disease – Overview, Definition, Patient Selection for Radical Approaches
Lunch Symposium Lunch Symposium / Panel Discussion
Session 3: Early Stage Disease Session 7: Advanced II
Role of Minimally Invasive Techniques (Robotics / VATS) and Sublobar Resections for Early Stage Lung Cancer Medonco: Immunology Landscape in Metastatic NSCLC
Radiation: SBRT, Radical RT Oncogene-Driven Tumours – Updates
Bronchoscopic Approaches to Early Stage Lung Cancer Rationale for Combinatorial Strategies in Advanced NSCLC
Tea Symposium Tea Symposium
Session 4: Locally Advanced Disease (Stage III Tumor Board) Session 8: Palliative / Supportive Care
N2 Case Presentation Palliative Care: Optimal Time to Start Palliative Care
Surgical Oncology Perspective Radiation: Mx of CNS Mets (SRS, WBRT)
Radiation Oncology Perspective Bronchoscopic / Pleural Interventions (Eg. IPC, Pleurex) for Palliation
Medical Oncology Perspective IO Toxicity
Best Poster Award
Discussion and Q&A Closing Remarks
End of Day 1 End of Conference
Translate »